UK MHRA First-Half New Drug Approvals Show Overwhelming Use Of EU Reliance Procedures
Executive Summary
The UK regulator approved 16 medicines containing a new active substance in the first half of this year, while the European Commission issued marketing authorizations for 20 NAS-containing drugs.